Arotech Reports Third Quarter 2019 Results

Date : 11/06/2019 @ 9:05PM
Source : GlobeNewswire Inc.
Stock : Arotech Corporation (ARTX)
Quote : 2.99  0.0 (0.00%) @ 11:00PM

Arotech Reports Third Quarter 2019 Results

Arotech (NASDAQ:ARTX)
Historical Stock Chart

2 Months : From Oct 2019 to Dec 2019

Click Here for more Arotech Charts.

Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter and nine months ended September 30, 2019.

Third Quarter 2019 Financial Summary:

ConsolidatedNine months endedSeptember 30, Three months endedSeptember 30,
U.S. $ in thousands, except per share data2019 2018 2019 2018
GAAP Measures       
Revenue$67,619  $72,968  $23,574  $23,844 
Gross profit$21,434  $21,639  $7,976  $7,328 
Net income (loss)$(1,078) $1,420  $(63) $741 
Diluted net income (loss) per share$(0.04) $0.05  $0.00  $0.03 
Net cash (used in) provided by operating activities$(595) $3,382  $3,000  $(266)
Non-GAAP Measures (reconciliation to GAAP measures appears in the tables below)
Adjusted EBITDA$4,301  $6,042  $2,455  $2,366 
Adjusted net income$1,544  $3,743  $1,490  $1,604 
Adjusted net income per share$0.06  $0.14  $0.06  $0.06 

Third Quarter 2019 Segment Results:

Training and Simulation DivisionNine months endedSeptember 30, Three months endedSeptember 30,
U.S. $ in thousands2019 2018 2019 2018
Revenue$44,253  $43,576  $14,894  $14,666 
Gross profit$18,224  $18,064  $6,412  $5,976 
Gross profit %41.2% 41.5% 43.1% 40.7%
        
Power Systems DivisionNine months endedSeptember 30, Three months endedSeptember 30,
U.S. $ in thousands2019 2018 2019 2018
Revenue$23,366  $29,391  $8,680  $9,179 
Gross profit$3,210  $3,574  $1,564  $1,351 
Gross profit %13.7% 12.2% 18.0% 14.7%

Third Quarter Financial Summary

Revenues for the third quarter of 2019 were $23.6 million, compared to $23.8 million for the corresponding period in 2018, a decrease of 1.1%, primarily due to lower revenues in our Power Systems Division related to the termination of the Company’s Amphibious Assault Vehicle program (“AAV”) by its customer Science Applications International Corporation (“SAIC”) as a result of the United States Marine Corps termination for convenience.

Gross profit for the third quarter of 2019 was $8.0 million, or 33.8% of revenues, compared to $7.3 million, or 30.7% of revenues, for the corresponding period in 2018. The year-over-year increase was primarily due to higher revenues and improved margins in the Company’s Power System Division related to programs that ended in 2018 that had lower margins along with improved product mix in 2019.

Operating expenses were $7.5 million, or 31.6% of revenues, in the third quarter of 2019, compared to operating expenses of $6.2 million, or 25.9% of revenues, for the corresponding period in 2018.  Operating expenses were higher year-over-year primarily due to costs associated with the potential merger and costs associated with the implementation of a corporate Enterprise Resource Planning (“ERP”) system in 2019.

Operating income for the third quarter was $520,000 compared to operating income of $1.1 million in the corresponding period in 2018.

Arotech’s net loss for the third quarter of 2019 was $63,000, or $0.00 per basic and diluted share, compared to net income of $741,000, or $0.03 per basic and diluted share, for the corresponding period in 2018.

Adjusted net income per share for the third quarter of 2019 and 2018 was $0.06, respectively, compared to $0.06.

Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) for the third quarter of 2019 was $2.5 million, compared to $2.4 million for the corresponding period of 2018.

Arotech believes information concerning Adjusted EBITDA and Adjusted net income per share enhances overall understanding of Arotech’s current financial performance. Arotech computes Adjusted EBITDA and Adjusted net income per share, which are non-GAAP financial measures, as reflected in the tables below.

Year-to-Date Financial Summary

Revenues for the first nine months of 2019 were $67.6 million, compared to $73.0 million for the comparable period in 2018, a decrease of 7.3%. In the first nine months of 2019, revenues were $44.3 million for the Training and Simulation Division as compared to $43.6 million in the first nine months of 2018, an increase of $676,000, or 1.6%, primarily driven by its larger military contracts and strong commercial vehicle sales. Revenues for the first nine months of 2019 in the Power Systems Division decreased by $6.0 million, or 20.5%, from $29.4 million in the first nine months of 2018 to $23.4 million in the first nine months of 2019, primarily due to the termination of our AAV program by our customer SAIC as a result of the Marines termination for convenience with SAIC on October 3, 2018, lower revenues associated with completed programs as well as less demand for certain of our customer products.

Gross profit for the first nine months of 2019 was $21.4 million, or 31.7% of revenues, compared to $21.6 million, or 29.7% of revenues, for the prior year period. The year-over-year decrease in gross profit was primarily due to lower revenues, offset by improved gross profit margins in the Power System Division related to programs that ended in 2018 that had lower margins along with improved product mix in 2019.

Operating expenses were $20.9 million, or 31.0% of revenues, for the first nine months of 2019, compared to operating expenses of $18.9 million, or 25.9% of revenues, for the corresponding period in 2018. Operating expenses are higher year-over-year primarily due to costs associated with the potential merger, higher R&D costs related to new projects, and costs related to an implementation of a corporate ERP system in 2019.

Operating income for the first nine months of 2019 was $502,000 compared to operating income of $2.8 million in the corresponding period in 2018.

Arotech’s net loss for the first nine months of 2019 was $1.1 million, or $(0.04) per basic and diluted share, compared to net income of $1.4 million, or $0.05 per basic and diluted share, for the corresponding period in 2018.

Adjusted net income per share for the first nine months of 2019 was $0.06, compared to $0.14 for the corresponding period in 2018.

Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) for the first nine months of 2019 was $4.3 million, compared to $6.0 million for the corresponding period of 2018.

Arotech believes information concerning Adjusted EBITDA and Adjusted net income per share enhances overall understanding of Arotech’s current financial performance. Arotech computes Adjusted EBITDA and Adjusted net income per share, which are non-GAAP financial measures, as reflected in the tables below.

Cash Flow Summary

Arotech had net cash used in operating activities of $595,000 for the period ending September 30, 2019, compared to cash provided by operating activities of $3.4 million for the corresponding period in 2018.  This use of cash is primarily attributable to the funding of certain long term contracts in the Training and Simulation Division, where milestone payments do not apply, as well as costs incurred prior to the termination of the AAV program.   In July 2019, the Company received a $2.0 million partial payment towards the AAV program costs and the funding of the long term contracts in our Training and Simulation division should be significantly completed by the second quarter of 2020.

Balance Sheet Metrics

U.S. $ in thousandsFor the Periodended September 30, For the Periodended December 31,
Balance Sheet Metrics2019 2018
Cash and cash equivalents$5,355  $4,445 
Total debt$19,175  $14,066 
Line of credit availability$11,765  $8,219 

As of September 30, 2019, Arotech had total debt of $19.2 million, consisting of $10.3 million in short-term bank debt under Arotech’s credit facilities and $8.8 million in long-term loans. This is in comparison to December 31, 2018, when Arotech had total debt of $14.1 million, consisting of $5.5 million in short-term bank debt under its credit facility and $8.6 million in long-term loans.  The increase in debt is related to the funding of certain long term contracts in the Company’s Training and Simulation Division and the terminated AAV program which has not been fully settled.

The Company had a current ratio (current assets/current liabilities) of 1.7, compared with the December 31, 2018 current ratio of 2.0.

Arotech’s backlog decreased 4.3% over the same period last year and increased 4.2% over the period ending December 31, 2018.

Backlog Summary

U.S. $ in millionsFor the Period Ended,
BacklogQ3 2019 Q3 2018 Q4 2018
Total$67.6  $70.7  $64.8 

Pending Acquisition of the Company

On September 22, 2019, Arotech entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Argonaut Intermediate, Inc., a Delaware corporation (“Parent”), an affiliate of Greenbriar Equity Group, L.P., and Argonaut Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent (“Merger Sub”), providing for the acquisition of Arotech by Parent. Pursuant to the terms of the Merger Agreement, Merger Sub will, at the closing of the transactions contemplated by the Merger Agreement, merge with and into Arotech, and Arotech will survive the merger as a wholly-owned subsidiary of Parent.

About Arotech Corporation

Arotech Corporation is a defense and security company engaged in two business areas: interactive simulation and mobile power systems.

Arotech is incorporated in Delaware, with corporate offices in Ann Arbor, Michigan, and research, development and production subsidiaries in Michigan, South Carolina, and Israel. For more information on Arotech, please visit Arotech’s website at www.arotech.com.

Additional Information about the Proposed Merger Transaction and Where to Find It

This communication relates to the proposed merger transaction involving Arotech Corporation (“Arotech”) and may be deemed to be solicitation material in respect of the proposed merger transaction. In connection with the proposed merger transaction, Arotech filed a definitive proxy statement on Schedule 14A (the “Proxy Statement”) with the SEC on November 4, 2019. This communication is not a substitute for the Proxy Statement or for any other document that Arotech may file with the SEC or send to Arotech’s stockholders in connection with the proposed merger transaction. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS OF AROTECH ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT AROTECH, THE PROPOSED MERGER TRANSACTION AND RELATED MATTERS. The proposed merger transaction will be submitted to Arotech’s stockholders for their consideration. Investors and security holders will be able to obtain free copies of the Proxy Statement (when available) and other documents filed by Arotech with the SEC through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed by Arotech with the SEC will also be available free of charge on Arotech’s website at www.arotech.com or by contacting Arotech’s Investor Relations contact at Scott.Schmidt@arotechusa.com.

Participants in the Solicitation

Arotech and its directors and certain of its executive officers and employees may be deemed to be participants in the solicitation of proxies from Arotech’s stockholders with respect to the proposed merger transaction under the rules of the SEC. Information about the directors and executive officers of Arotech and their ownership of shares of Arotech’s common stock is set forth in its Annual Report on Form 10-K for the year ended December 31, 2018, which was filed with the SEC on March 7, 2019, its proxy statement for its 2019 annual meeting of stockholders, which was filed with the SEC on March 22, 2019 and in subsequent documents filed with the SEC, including the Proxy Statement. Additional information regarding the persons who may be deemed participants in the proxy solicitations and a description of their direct and indirect interests in the merger transaction, by security holdings or otherwise, will also be included in the Proxy Statement and other relevant materials to be filed with the SEC when they become available. You may obtain free copies of this document as described above.

Cautionary Statement Regarding Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Arotech generally identifies forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar words. These statements are only predictions. Arotech has based these forward-looking statements largely on its then-current expectations and projections about future events and financial trends as well as the beliefs and assumptions of management. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Arotech’s control. Arotech’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: (i) risks associated with Arotech’s ability to obtain the stockholder approval required to consummate the proposed merger transaction and the timing of the closing of the proposed merger transaction, including the risks that a condition to closing would not be satisfied within the expected timeframe or at all or that the closing of the proposed merger transaction will not occur; (ii) the outcome of any legal proceedings that may be instituted against the parties and others related to the merger agreement; (iii) the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the merger agreement, (iv) unanticipated difficulties or expenditures relating to the proposed merger transaction, the response of business partners and competitors to the announcement of the proposed merger transaction, and/or potential difficulties in employee retention as a result of the announcement and pendency of the proposed merger transaction; and (v) those risks detailed in Arotech’s most recent Annual Report on Form 10-K and subsequent reports filed with the SEC, as well as other documents that may be filed by Arotech from time to time with the SEC. Accordingly, you should not rely upon forward-looking statements as predictions of future events. Arotech cannot assure you that the events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. The forward-looking statements made in this communication relate only to events as of the date on which the statements are made. Except as required by applicable law or regulation, Arotech undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

Investor Relations Contact:

Scott SchmidtArotech Corporation1-800-281-0356Scott.Schmidt@arotechusa.com

Except for the historical information herein, the matters discussed in this news release include forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, readers are cautioned not to place undue reliance on these forward-looking statements, as they are subject to various risks and uncertainties that may cause actual results to vary materially. These risks and uncertainties include, but are not limited to, risks relating to: product and technology development; the uncertainty of the market for Arotech’s products; changing economic conditions; delay, cancellation or non-renewal, in whole or in part, of contracts or of purchase orders (including as a result of budgetary cuts resulting from automatic sequestration under the Budget Control Act of 2011); and other risk factors detailed in Arotech’s most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2018, and other filings with the Securities and Exchange Commission. Arotech assumes no obligation to update the information in this release. Reference to Arotech’s website above does not constitute incorporation of any of the information thereon into this press release.

 
CONDENSED CONSOLIDATED BALANCE SHEET SUMMARY (UNAUDITED)(U.S. Dollars)
 
 
 For the Periodended September 30, For the Periodended December 31,
 2019 2018
ASSETS   
CURRENT ASSETS:   
Cash and cash equivalents$5,196,806  $4,222,246 
Restricted collateral deposits157,775  222,712 
Trade receivables, net17,163,788  16,259,809 
Contract assets24,970,939  17,867,896 
Other accounts receivable and prepaid expenses3,628,600  5,989,263 
Inventories, net8,905,529  9,912,748 
Total current assets60,023,437  54,474,674 
LONG TERM ASSETS:   
Contractual and Israeli statutory severance pay fund3,883,947  3,427,705 
Other long term receivables537,007  543,205 
Property and equipment, net9,504,583  8,914,247 
Right of use asset5,887,243   
Other intangible assets, net4,919,657  4,465,778 
Goodwill46,138,036  46,138,036 
Total long term assets70,870,473  63,488,971 
Total assets$130,893,910  $117,963,645 
    
LIABILITIES AND STOCKHOLDERS’ EQUITY   
CURRENT LIABILITIES:   
Trade payables$7,882,797  $6,442,919 
Other accounts payable and accrued expenses6,245,907  6,498,045 
Current portion of lease obligation628,294   
Current portion of long term debt2,983,905  2,204,653 
Short term bank credit10,334,840  5,500,416 
Contract liabilities7,504,965  7,054,779 
Total current liabilities35,580,708  27,700,812 
LONG TERM LIABILITIES:   
Contractual and accrued Israeli statutory severance pay4,682,611  4,125,675 
Long term portion of lease obligations5,569,696   
Long term portion of debt5,856,494  6,360,569 
Deferred income tax liability3,219,008  2,863,098 
Other long term liabilities42,364  137,774 
Total long-term liabilities19,370,173  13,487,116 
Total liabilities54,950,881  41,187,928 
STOCKHOLDERS’ EQUITY:   
Total stockholders’ equity75,943,029  76,775,717 
Total liabilities and stockholders’ equity$130,893,910  $117,963,645 
    

 
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)  (U.S. Dollars, except share data)
 
 Nine months ended September 30, Three months ended September 30,
 2019 2018 2019 2018
Revenues$67,618,934  $72,967,596  $23,573,731  $23,844,477 
        
Cost of revenues46,185,133  51,328,827  15,597,611  16,516,663 
Research and development expenses3,206,207  2,518,787  1,110,285  753,792 
Selling and marketing expenses6,214,200  5,647,284  1,870,739  1,837,823 
General and administrative expenses10,579,909  9,413,379  4,193,949  3,201,566 
Amortization of intangible assets931,527  1,298,573  280,662  391,831 
Total operating costs and expenses67,116,976  70,206,850  23,053,246  22,701,675 
        
Operating income501,958  2,760,746  520,485  1,142,802 
        
Other income (expense), net(9,944) 5,878  (853) (1,521)
Financial expense, net(1,066,027) (696,232) (396,170) (173,345)
Total other expense(1,075,971) (690,354) (397,023) (174,866)
Income (loss) before income tax expense(574,013) 2,070,392  123,462  967,936 
        
Income tax expense504,047  650,765  186,785  227,380 
Net income (loss)(1,078,060) 1,419,627  (63,323) 740,556 
Other comprehensive income (loss), net of income tax:       
Foreign currency translation adjustment67,270  (66,162)   13,100 
Comprehensive income (loss)(1,010,790) 1,353,465  (63,323) 753,656 
        
Basic net income (loss) per share$(0.04) $0.05  $  $0.03 
Diluted net income (loss) per share$(0.04) $0.05  $  $0.03 
Weighted average number of shares used in computing basic net income (loss) per share26,547,045 26,466,948 26,547,045 26,486,152
Weighted average number of shares used in computing diluted net income (loss) per share26,547,045 26,466,948 26,547,045 26,486,152
        

Reconciliation of Non-GAAP Financial Measure – Continuing Operations

To supplement Arotech’s consolidated financial statements presented in accordance with U.S. GAAP, Arotech uses a non-GAAP measure, Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA). This non-GAAP measure is provided to enhance overall understanding of Arotech’s current financial performance. Reconciliation of the nearest GAAP measure to adjusted EBITDA follows:

 Nine months ended September 30, Three months ended September 30, 
 2019 2018 2019 2018 
Net income (loss) (GAAP measure)$(1,078,060) $1,419,627  $(63,323) $740,556  
Add back:        
Financial expense – including interest1,075,971  690,354  397,023  174,866  
Income tax (benefit) expense504,047  650,765  186,785  227,380  
Depreciation and amortization expense2,465,660  2,764,289  802,889  896,989  
Other adjustments*1,333,590  516,654  1,131,461  326,385  
Total adjusted EBITDA$4,301,208  $6,041,689  $2,454,835  $2,366,176  
                 

                                                                                                                          * Includes stock compensation expense, one-time transaction expenses and other non-cash expenses.

 
CALCULATION OF ADJUSTED NET INCOME PER SHARE
 
(U.S. $ in thousands, except per share data)
 
 Nine months ended September 30, Three months ended September 30, 
 2019 2018 2019 2018 
Revenue (GAAP measure)$67,619  $72,968  $23,574  $23,844  
Net income (loss) (GAAP measure)$(1,078) $1,420  $(63) $741  
Adjustments:        
Amortization932  1,299  281  392  
Stock compensation291  492  89  301  
Non-cash taxes356  507  140  145  
Other non-recurring expenses1,043  25  1,043  25  
Net adjustments$2,622  $2,323  $1,553  $863  
Adjusted net income$1,544  $3,743  $1,490  $1,604  
Number of diluted shares26,665 26,467 26,665 26,486  
Adjusted net income per share$0.06  $0.14  $0.06  $0.06  
                 

Latest ARTX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.